Kiniksa Pharmaceuticals International (KNSA) Property, Plant & Equipment (Net) (2017 - 2026)
Powered by 
Analysis
Kiniksa Pharmaceuticals International (KNSA) Property, Plant & Equipment (Net) (2017 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Property, Plant & Equipment (Net) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 212.04 Bn | 198.05 Bn | 7.24 Bn | 8.55 Bn |
| 2 | Gilead Sciences | 181.35 Bn | 178.17 Bn | 6.22 Bn | 5.83 Bn |
| 3 | Vertex Pharmaceuticals | 132.22 Bn | 124.37 Bn | 2.84 Bn | 1.67 Bn |
| 4 | Regeneron Pharmaceuticals | 82.94 Bn | 74.94 Bn | 3.93 Bn | 5.46 Bn |
| 5 | Argenx Se | 61.53 Bn | 56.34 Bn | 1.37 Bn | 1.96 Bn |
| 6 | Moderna | 54.25 Bn | 49.11 Bn | 52.00 Mn | 2.06 Bn |
| 7 | Alnylam Pharmaceuticals | 34.41 Bn | 31.10 Bn | 992.69 Mn | 554.14 Mn |
| 8 | Biogen | 31.19 Bn | 29.91 Bn | 1.96 Bn | 2.99 Bn |
| 9 | Roivant Sciences | 30.10 Bn | 30.10 Bn | 1.16 Mn | 11.32 Mn |
| 10 | Kiniksa Pharmaceuticals International | 6.12 Bn | 5.60 Bn | 220.03 Mn | 2.58 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.58 Mn |
| Mar 31, 2026 | 1.99 Mn |
| Dec 31, 2025 | 1.94 Mn |
| Sep 30, 2025 | 1.66 Mn |
| Jun 30, 2025 | 1.08 Mn |
| Mar 31, 2025 | 606,000.00 |
| Dec 31, 2024 | 662,000.00 |
| Sep 30, 2024 | 561,000.00 |
| Jun 30, 2024 | 625,000.00 |
| Mar 31, 2024 | 712,000.00 |
| Dec 31, 2023 | 734,000.00 |
| Sep 30, 2023 | 918,000.00 |
| Jun 30, 2023 | 1.14 Mn |
| Mar 31, 2023 | 1.39 Mn |
| Dec 31, 2022 | 1.66 Mn |
| Sep 30, 2022 | 2.00 Mn |
| Jun 30, 2022 | 2.15 Mn |
| Mar 31, 2022 | 2.48 Mn |
| Dec 31, 2021 | 2.83 Mn |
| Sep 30, 2021 | 3.17 Mn |